A. SARICI Et Al. , "Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients," TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.4, 2021
SARICI, A. Et Al. 2021. Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients. TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.4 .
SARICI, A., ERKURT, M. A., Bahcecioglu, O. F., Gok, S., KUKU, İ., Bicim, S., ... BERBER, İ.(2021). Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients. TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.4.
SARICI, AHMET Et Al. "Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients," TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.4, 2021
SARICI, AHMET Et Al. "Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients." TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.4, 2021
SARICI, A. Et Al. (2021) . "Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients." TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.4.
@article{article, author={AHMET SARICI Et Al. }, title={Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients}, journal={TRANSFUSION AND APHERESIS SCIENCE}, year=2021}